Search results
Items from 21 to 21 out of 21 results
Pharmacology
Acetylsalicylic Acid > 33 - 127
This chapter contains sections titled:
Pharmacokinetics
Cellular Modes of Action
Actions on Organs and Tissues
Add recipient
Filter options
Publication date
- Set your own date range
Date range setting
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.
From:
To:
Keywords
- DRUG METABOLISM (3)
- EPILEPSY (3)
- PHARMACODYNAMICS (3)
- STRUCTURE‐ACTIVITY RELATIONSHIP (3)
- TOXICOKINETICS (3)
- ANTIEPILEPTIC DRUG (2)
- ANTIEPILEPTIC DRUGS (2)
- BRIVARACETAM (2)
- ABSORPTION (1)
- ACTH AND CORTICOSTEROIDS AND ADVERSE EFFECTS (1)
- ACTIVITY IN EXPERIMENTAL MODELS OF SEIZURE AND EPILEPSY (1)
- ACTIVITY IN NON‐EPILEPSY INDICATIONS (1)
- ADRENOCORTICOTROPIC HORMONE (ACTH) AND CORTICOSTEROIDS (1)
- ADRENOCORTICOTROPIC HORMONE AND CORTICOSTEROIDS (1)
- ADVERSE DRUG REACTIONS (1)
- AGE (1)
- AMPA RECEPTOR ANTAGONIST (1)
- ANESTHETIC DRUGS (1)
- ANESTHETIC MANAGEMENT (1)
- ASPIRIN (1)
- BENZODIAZEPINE (1)
- BIOAVAILABILITY (1)
- BIOMARKERS (1)
- BIOTRANSFORMATION (1)
- BLOOD–BRAIN BARRIER (BBB) (1)
- BONE DENSITY (1)
- BRIVARACETAM PHARMACOKINETICS (1)
- CARBOCYCLIC NUCLEOSIDE (1)
- CARDIOVASCULAR SYSTEM (1)
- CENTRAL NERVOUS SYSTEM (CNS) PENETRATION (1)
- CENTRAL NERVOUS SYSTEM DISORDER (1)
- CHINESE HERBAL MEDICINE (1)
- CHRONIC HEPATITIS B (1)
- CLINICAL TRIALS (1)
- CORTICOSTEROID METABOLISM (1)
- CYCLOOXYGENASES (1)
- DIAZEPAM PHARMACOKINETIC PARAMETERS (1)
- DIAZEPAM, LORAZEPAM AND MIDAZOLAM (1)
- DISCOVERY SYNTHESES (1)
- DISTRIBUTION (1)
- DRUG DEVELOPMENT (1)
- DRUG ELIMINATION (1)
- DRUG INTERACTIONS (1)
- DRUG SAFETY EVALUATION (1)
- EFFICACY (1)
- ELDERLY (1)
- ELDERLY PATIENTS (1)
- ENTECAVIR (1)
- ENZYME INDUCTION (1)
- ENZYME INHIBITION (1)
- ENZYME‐INDUCING ANTIEPILEPTIC DRUGS (AEDS) (1)
- EPILEPTIC SYNDROMES (1)
- EXCRETION (1)
- FDA (1)
- FEBUXOSTAT (1)
- FIBRINOLYSIS (1)
- GAMMA‐AMINOBUTYRIC ACID (GABA) RECEPTORS (1)
- GASTRIC EMPTYING (1)
- GENOTOXICITY STUDIES (1)
- GERIATRIC (1)
- GERIATRIC PATIENTS (1)
- GINGKO BILOBA (1)
- GOUT (1)
- HUMAN TOLERANCE (1)
- IN SILICO PREDICTION (1)
- INTESTINAL BARRIER (1)
- KINETICS (1)
- LESINURAD SODIUM (1)
- LIVER FUNCTION (1)
- LORAZEPAM PHARMACOKINETIC PARAMETERS (1)
- LORAZEPAM ‐ EXTREMELY POTENT ANTICONVULSANT (1)
- MEMBRANE PERMEATION (1)
- METABOLISM (1)
- MOTOR INCOORDINATION (1)
- NEUROPK (1)
- OLDER ADULTS (1)
- OLDER PATIENTS (1)
- ONCOGENICITY (1)
- PERAMPANEL (1)
- PHARMACOGENETICS (1)
- PHARMACOKINETIC (PK) PARAMETERS (1)
- PHARMACOLOGIC PARAMETERS (1)
- PHARMCODYNAMICS (1)
- PHENYTOIN (1)
- PHYSIOLOGICALLY BASED PHARMACOKINETICS (1)
- PHYTOMEDICINE (1)
- PRE‐OPERATIVE ASSESSMENT (1)
- PROOF‐OF‐CONCEPT IN PHOTOSENSITIVE EPILEPSY (1)
- PROTEIN BINDING DISPLACEMENT (1)
- RANDOMIZED FLEXIBLE‐DOSE ADJUNCTIVE‐THERAPY (1)
- RENAL FUNCTION (1)
- RENAL SYSTEM (1)
- REPEATED‐DOSE ORAL ADMINISTRATION OF BRIVARACETAM (1)
- REPRODUCTIVE TOXICITY (1)
- RESPIRATORY SYSTEM (1)
- RETICULAR ACTIVATING SYSTEM (1)
- RNA (1)
- SAFETY (1)
- SALICYLIC ACID (1)
- more